why did fda ban tirzepatide BANS Compounded Tirzepatide! Now What? Tirzepatide, FDA, and Compounding: Understanding

GLP-1 medications are generally intended for long-term use and stopping them is not recommended without first speaking with a doctor

Insurance coverage for PCOS-related use often varies, as it's considered an off-label prescription

Gastrointestinal side effects can return during the transition, especially when starting or increasing doses

an injection skips the gut entirely and delivers a full, reliable dose

Our team provides medical evaluations, prescribes your treatment, and supports you with regular check-insall from the comfort of your home

Understanding why these symptoms occur, how common they are, and what can be done to manage them is essential for patients starting or considering GLP-1 therapy